Chemours
476 hedge funds and large institutions have $4.23B invested in Chemours in 2023 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 118 increasing their positions, 159 reducing their positions, and 76 closing their positions.
31% more capital invested
Capital invested by funds: $3.23B → $4.23B (+$1B)
4.44% more ownership
Funds ownership: 72.52% → 76.95% (+4.4%)
10% more call options, than puts
Call options by funds: $102M | Put options by funds: $92.7M
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
2% less funds holding
Funds holding: 487 → 476 (-11)
11% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 76
26% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 159
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$112M |
| 2 |
Bank of New York Mellon
New York
|
+$110M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$50.5M |
| 4 |
DRZID
DePrince Race & Zollo Inc (DRZ)
Winter Park,
Florida
|
+$30M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$28.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$38.7M |
| 2 |
Millennium Management
New York
|
-$27M |
| 3 |
SC
Sessa Capital
New York
|
-$24.5M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$24.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$19.1M |
CC Hedge Fund Activity: Q2 2023 in Review
476 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2023, worth a combined $4.23B — up 31% from $3.23B a quarter earlier.
Sellers outnumbered buyers: 76 funds closed out of CC and 68 opened new positions — a net loss of 8 holders — while 159 trimmed existing stakes and 118 added.
The largest buyer was Fidelity Investments, adding an estimated $112M. The largest seller was Vanguard Group, cutting an estimated $38.7M.
- 476 institutional investors held Chemours (CC) as of Q2 2023, down from 487 in Q1 2023.
- Funds reported $4.23B of Chemours stock for Q2 2023, up 31% quarter-over-quarter.
- 68 funds opened new Chemours positions in Q2 2023 and 76 closed out, a net change of -8 holders.
- The largest Chemours buyer in Q2 2023 was Fidelity Investments, an estimated $112M added.
- The largest Chemours seller in Q2 2023 was Vanguard Group, an estimated $38.7M sold.
Based on aggregated 13F filings for Q2 2023.